Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Merck Announces First-of-its Kind Filters for CHO & Downstream Filtration Applications
<p>Merck announced Millistak+® HC Pro, the first of its kind high capacity, fully synthetic depth filters for non-treated Chinese Hamster Ovary (CHO) harvest clarification and downstream filtration applications.</p> <p>Millistak+® HC Pro filter media provides a cleaner and more consistent depth filtration process compared with traditional diatomaceous earth (DE) and cellulose-based filtration processes.</p> <p>The Millistak+® HC Pro portfol...
Pfizer Launches First-of-its Kind Innovative Technologies for Hemophilia Patients
<p>Pfizer announced the launch of Hemocraft™ a modification of the popular video game Minecraft®, and the HemMobile® Striiv® Wearable, a custom wristband. It helps people who suffer with hemophilia with better approaches and activity tracking in the US.</p> <p>Hemocraft helps younger individuals with hemophilia, 8-16 years of age, to learn the importance of integrating treatment into their routine in an educational and fun gaming environment.<...
Breakthrough Therapy Designation to Adcetris for Frontline Advanced Hodgkin Lymphoma
<p>ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the frontline treatment of patients with advanced classical Hodgkin lymphoma has been granted breakthrough therapy designation by FDA.</p> <p>ADCETRIS is an antibody drug conjugate (ADC) directed to CD30, a defining marker of classical Hodgkin lymphoma.</p> <p>It is being evaluated globally as the foundation of care for CD30-expressing lymphomas in more than 70 corporate...
Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough Designation"
<p>Sanofi and Regeneron announced that Cemiplimab (REGN2810) has received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma.</p> <p>Cemiplimab is an investigational human, monoclonal antibody targeting PD-1. It would be used to treat adults with metastatic cutaneous squamous cell carcinoma (CSCC) and adults with locally advanced and unresectable CSCC, the second deadliest skin cancer after melanoma.</p> <p>...
New Drug Development Workflow Designed for Extrusion-Based Drug Implant Production
<p>The Thermo Scientific Pharma mini implant line, first end-to-end solution, is an automated, integrated system designed for continuous production of drug implants.</p> <p>Drug formulation scientists can use the first commercially available, fully integrated solution for polymer-based drug implant development and production using Hot Melt Extrusion (HME) to meet growing demand for innovative drug delivery systems in the pharmaceutical industr...
Potential Breakthrough Therapy for Cancer based on Pepscan’s CLIPS Technology
<p>Pepscan announced that there is an important progress with a drug development program based on its CLIPS technology.</p> <p>Bicycle Therapeutics team in the UK applied Pepscan’s CLIPS technology to identify a bicyclic CLIPS peptide that selectively binds to a protein (MT1-MMP) present on tumor cells.</p> <p>A toxin payload has been linked to the high affinity bicyclic peptide to create a ‘Bicycle Drug Conjugate (BDC)’.</p> <p>The comp...
World’s First Cell and Gene Therapy for Knee Osteoarthritis Gets Approval
<p>The world’s first cell and gene therapy for knee osteoarthritis (Invossa-K Inj.) gets approval from the Korea Ministry of Food and Drug Safety (MFDS).</p> <p>This therapy was manufactured by Kolon Life Science and it has received exclusive licensee for Asia, including Korea.</p> <p>Invossa is a first-in-class cell-mediated gene therapy designed to treat moderate (Kellgren and Lawrence grade 3) knee osteoarthritis through regeneration of ...
New Method for Residual Solvent Characterization by GC-VUV
<p>A new method has been announced by VUV Analytics, for residual solvent testing in pharmaceutical products and excipients that significantly reduces analysis time while improving testing throughput.</p> <p>It allows the combination of various sample types into a single test. The gas chromatography – Vacuum Ultraviolet (GC-VUV) spectroscopy method reduces the GC separation time recommended by the Unites States Pharmacopeia (USP) Method 467 of...
MagBio Launches its Novel cfKapture 21 Kit
<p>MagBio Genomics announces the launch of its new cfKapture 21 kit. cfKapture 21 kit is said to be a novel solution for isolation of circulating Cell-Free DNA (ccfDNA) from stabilized plasma sample.</p> <p>cfKapture 21 system is a ccfDNA isolation kit which includes a proprietary reagent that prevents post-separation degradation of plasma and ccfDNA fragments for up to 21 days at room temperature.</p> <p>Laboratories can easily and safely ...
Evotec and Eternygen to Develop Novel Metabolic Disease Therapy
<p>Evotec and Eternygen announced a drug discovery collaboration to develop novel metabolic disease therapy.</p> <p>The two companies will develop novel small molecule inhibitors against an Eternygen target to treat metabolic disease using Evotec’s technology platform and broad expertise in drug discovery and pre-clinical development.</p> <p>Eternygen is working on the sodium coupled citrate transporter NaCT, a novel target which is a key r...
